tiprankstipranks
Trending News
More News >
Zydus Wellness Limited (IN:ZYDUSWELL)
:ZYDUSWELL
India Market

Zydus Wellness Limited (ZYDUSWELL) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

ZYDUSWELL Financial Forecast

ZYDUSWELL Earnings Forecast

The previous quarter’s earnings for ZYDUSWELL were ₹27.00.
The previous quarter’s earnings for ZYDUSWELL were ₹27.00.

ZYDUSWELL Sales Forecast

The previous quarter’s earnings for ZYDUSWELL were ₹9.13B.
The previous quarter’s earnings for ZYDUSWELL were ₹9.13B.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
ICICI Securities Analyst forecast on IN:ZYDUSWELL
Manoj MenonICICI Securities
ICICI Securities
₹2,200₹2,000
Buy
9.23%
Upside
Reiterated
02/05/25
Zydus Wellness Ltd (ZYWL:IN) PT Lowered to INR2,000 at ICICI SecuritiesICICI Securities analyst Manoj Menon lowered the price target on Zydus Wellness Ltd (ZYWL:IN) to INR2,000.00 (from INR2,200.00) while maintaining a Add (2) rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
ICICI Securities Analyst forecast on IN:ZYDUSWELL
Manoj MenonICICI Securities
ICICI Securities
₹2,200₹2,000
Buy
9.23%
Upside
Reiterated
02/05/25
Zydus Wellness Ltd (ZYWL:IN) PT Lowered to INR2,000 at ICICI SecuritiesICICI Securities analyst Manoj Menon lowered the price target on Zydus Wellness Ltd (ZYWL:IN) to INR2,000.00 (from INR2,200.00) while maintaining a Add (2) rating.
Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector
Find stocks in the Consumer Defensive sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zydus Wellness Limited

1 Month
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-12.30%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -12.30% per trade.
3 Months
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-4.20%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -4.20% per trade.
1 Year
Manoj MenonICICI Securities
Success Rate
1/1 ratings generated profit
100%
Average Return
+11.00%
reiterated a buy rating 5 months ago
Copying Manoj Menon's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +11.00% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+11.00%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +11.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZYDUSWELL Analyst Recommendation Trends

Rating
Feb 25
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
total
1
In the current month, ZYDUSWELL has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ZYDUSWELL average Analyst price target in the past 3 months is 2,000.00.
Each month's total comprises the sum of three months' worth of ratings.

ZYDUSWELL Stock Forecast FAQ

What is IN:ZYDUSWELL’s average 12-month price target, according to analysts?
Based on analyst ratings, Zydus Wellness Limited’s 12-month average price target is 2,000.00.
    What is IN:ZYDUSWELL’s upside potential, based on the analysts’ average price target?
    Zydus Wellness Limited has 9.23% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Zydus Wellness Limited a Buy, Sell or Hold?
          Zydus Wellness Limited has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Zydus Wellness Limited’s share price target?
            The average share price target for Zydus Wellness Limited is 2,000.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is ₹2,000.00 ,and the lowest forecast is ₹2,000.00. The average share price target represents 9.23% Increase from the current price of ₹1,830.95.
              What do analysts say about Zydus Wellness Limited?
              Zydus Wellness Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of Zydus Wellness Limited?
                To buy shares of IN:ZYDUSWELL, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis